Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00616642 · BASELINE

Baseline characteristics

Rosiglitazone in Treating Patients With Pituitary Tumors · Source last updated 2020-08-14

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      0
    2. group Id
      BG001
      value
      1
    3. group Id
      BG002
      value
      1
    units
    Participants
groups
  1. description
    Patients receive 4 mg oral rosiglitazone maleate once daily in week 1 and then 8 mg once daily beginning in week 2 and continuing for up to 6 months in the absence of disease progression or unacceptable toxicity. rosiglitazone maleate : Given orally
    id
    BG000
    title
    Group 1 (ACTH-secreting Adenomas)
  2. description
    Patients receive 4 mg oral rosiglitazone maleate once daily in week 1 and then 8 mg once daily beginning in week 2 and continuing for up to 12 months in the absence of disease progression or unacceptable toxicity. rosiglitazone maleate : Given orally
    id
    BG001
    title
    Group 2 (Non-secreting Macroadenomas)
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG001
          value
          0
        2. group Id
          BG002
          value
          0
        title
        <=18 years
      2. measurements
        1. group Id
          BG001
          value
          1
        2. group Id
          BG002
          value
          1
        title
        Between 18 and 65 years
      3. measurements
        1. group Id
          BG001
          value
          0
        2. group Id
          BG002
          value
          0
        title
        >=65 years
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Age, Categorical
    unit Of Measure
    Participants
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG001
          value
          1
        2. group Id
          BG002
          value
          1
        title
        Female
      2. measurements
        1. group Id
          BG001
          value
          0
        2. group Id
          BG002
          value
          0
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG001
          value
          0
        2. group Id
          BG002
          value
          0
        title
        American Indian or Alaska Native
      2. measurements
        1. group Id
          BG001
          value
          0
        2. group Id
          BG002
          value
          0
        title
        Asian
      3. measurements
        1. group Id
          BG001
          value
          0
        2. group Id
          BG002
          value
          0
        title
        Native Hawaiian or Other Pacific Islander
      4. measurements
        1. group Id
          BG001
          value
          0
        2. group Id
          BG002
          value
          0
        title
        Black or African American
      5. measurements
        1. group Id
          BG001
          value
          1
        2. group Id
          BG002
          value
          1
        title
        White
      6. measurements
        1. group Id
          BG001
          value
          0
        2. group Id
          BG002
          value
          0
        title
        More than one race
      7. measurements
        1. group Id
          BG001
          value
          0
        2. group Id
          BG002
          value
          0
        title
        Unknown or Not Reported
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Race (NIH/OMB)
    unit Of Measure
    Participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      0
    2. group Id
      BG001
      value
      1
    3. group Id
      BG002
      value
      1
    units
    Participants
groups
  1. description
    Patients receive 4 mg oral rosiglitazone maleate once daily in week 1 and then 8 mg once daily beginning in week 2 and continuing for up to 6 months in the absence of disease progression or unacceptable toxicity. rosiglitazone maleate : Given orally
    id
    BG000
    title
    Group 1 (ACTH-secreting Adenomas)
  2. description
    Patients receive 4 mg oral rosiglitazone maleate once daily in week 1 and then 8 mg once daily beginning in week 2 and continuing for up to 12 months in the absence of disease progression or unacceptable toxicity. rosiglitazone maleate : Given orally
    id
    BG001
    title
    Group 2 (Non-secreting Macroadenomas)
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG001
          value
          0
        2. group Id
          BG002
          value
          0
        title
        <=18 years
      2. measurements
        1. group Id
          BG001
          value
          1
        2. group Id
          BG002
          value
          1
        title
        Between 18 and 65 years
      3. measurements
        1. group Id
          BG001
          value
          0
        2. group Id
          BG002
          value
          0
        title
        >=65 years
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Age, Categorical
    unit Of Measure
    Participants
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG001
          value
          1
        2. group Id
          BG002
          value
          1
        title
        Female
      2. measurements
        1. group Id
          BG001
          value
          0
        2. group Id
          BG002
          value
          0
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG001
          value
          0
        2. group Id
          BG002
          value
          0
        title
        American Indian or Alaska Native
      2. measurements
        1. group Id
          BG001
          value
          0
        2. group Id
          BG002
          value
          0
        title
        Asian
      3. measurements
        1. group Id
          BG001
          value
          0
        2. group Id
          BG002
          value
          0
        title
        Native Hawaiian or Other Pacific Islander
      4. measurements
        1. group Id
          BG001
          value
          0
        2. group Id
          BG002
          value
          0
        title
        Black or African American
      5. measurements
        1. group Id
          BG001
          value
          1
        2. group Id
          BG002
          value
          1
        title
        White
      6. measurements
        1. group Id
          BG001
          value
          0
        2. group Id
          BG002
          value
          0
        title
        More than one race
      7. measurements
        1. group Id
          BG001
          value
          0
        2. group Id
          BG002
          value
          0
        title
        Unknown or Not Reported
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Race (NIH/OMB)
    unit Of Measure
    Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice